[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"glasses\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:glasses":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,54,82],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":32,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":42,"lastUpdatePostDateStruct":43,"startDateStruct":46,"completionDateStruct":48,"leadSponsor":50,"locationsCount":53},"100610448","effect-of-vision-centers-on-access-to-eye-care-and-eye-health-outcomes-100610448",false,"NCT07227714","Effect of Vision Centers on Access to Eye Care and Eye Health Outcomes","A Cluster-Randomized Trial Evaluating the Effect of Vision Centers on Access to Eye Care and Eye Health Outcomes in South Asia","Inclusion Criteria:\n\n* The catchment area of the proposed VC site is predominantly rural.\n* The proposed VC site is located within 20-100 km of the base hospital.\n* There are no major primary eye care services within 10 km of the proposed site.\n* Care at sites randomized to establish VCs immediately is accessible to anyone.\n\nExclusion Criteria:\n\n* Sites located in non-rural or urban catchment areas.\n* Sites outside the 20-100 km distance range from the base hospital.\n* Sites with existing major primary eye care services within a 10 km radius.",true,"ALL",{"count":19,"type":20},150000,"ESTIMATED","INTERVENTIONAL",[23],"NA","This cluster-randomized trial aims to evaluate the effect of vision centers on access to eye care and eye health outcomes in South Asia. The main questions it aims to answer are:\n\n1. Do vision centers improve effective refractive error coverage?\n2. Do vision centers increase eye care center utilization?\n3. Do vision centers improve population visual acuity?\n\nResearchers will compare outcomes in communities randomized to immediate versus delayed establishment of a vision center. Outcomes will be assessed through population-based surveys at baseline and after two years as well as through hospital records collected throughout the study period.",[26,27,28,29,30,31],"Cataract Surgery","Eye Care","Glasses","Primary Eye Care","Vision Center","Eyecare Visits",[33,34,35,36,37,38,39,40],"vision center","primary eye care","cataract surgery","glasses","glassess ownership","spectacle ownership","cluster-randomized trial","eyecare visits","NOT_YET_RECRUITING","2026-06-26",{"date":44,"type":45},"2026-06-30","ACTUAL",{"date":47,"type":20},"2026-08-01",{"date":49,"type":20},"2028-12-01",{"name":51,"class":52},"University of California, San Francisco","OTHER",1,{"id":55,"slug":56,"hasResults":11,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":4,"eligibilityCriteria":60,"healthyVolunteers":11,"sex":17,"minAge":61,"maxAge":62,"enrollmentInfo":63,"targetDuration":4,"studyType":21,"phases":65,"briefSummary":67,"conditions":68,"keywords":4,"overallStatus":71,"whyStopped":4,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":81},"100601647","phase-4-quality-of-life-in-presbyopic-patients-who-are-treated-with-qlosi-100601647","NCT07113210","Quality of Life in Presbyopic Patients Who Are Treated With Qlosi","Understanding Quality of Life in Presbyopic Patients Who Are Treated With Qlosi","Inclusion Criteria:\n\n* Subjects who are 45-64 years old (inclusive) at the time of screening.\n* Be able and willing to provide written informed consent and sign a Health Information Portability and Accountability Act (HIPAA) form prior to any study procedure being performed.\n* Be able and willing to follow all instructions and attend study visits.\n* Have text messaging capabilities on their phone.\n* Self-reported complaints of near vision blur when fully corrected at distance.\n* Study confirmed near add that is between +0.75 D to +2.00 D OD\u002FOS (inclusive).\n* Spherical distance prescription between +1.00 D to -4.00 D OD\u002FOS (inclusive).\n* Cylinder power less than or equal to -1.00 D OD\u002FOS.\n* Best-corrected visual acuity (BCVA) at distance of 0.00 logMAR (20\u002F20 Snellen equivalent) or better OD\u002FOS.\n\nExclusion Criteria:\n\n* Known hypersensitivity to any ingredient in the study drops.\n* Any active ocular condition that may confound study results (e.g., dry eye, allergy, conjunctivitis, ocular infection).\n* Any use of prescription eye drops 1 week before screening or during the study.\n* Any past use of the study drops.\n* Any contact lens use for the duration of the study.\n* Artificial tears or lubricant eye drops use on the day of or during any study visits.\n* Clinically significant abnormal findings (e.g., central corneal scar) on a slit lamp exam in either eye documented at screening or a known history of a clinically significant slit-lamp finding in either eye that could confound study results.\n* Have had an ocular surgical intervention within 6 months of the screening visit or planned surgical intervention during the study.\n* A female of childbearing potential who is currently pregnant, nursing, or planning a pregnancy.\n* Any visible retinal findings noted upon a dilated fundus examination known to be a risk for use of study treatment (as determined by the investigator).","45 Years","64 Years",{"count":64,"type":20},36,[66],"PHASE4","The goal of this clinical trial is to determine how Qlosi™ (pilocarpine HCL ophthalmic solution) 0.4%impacts the quality of life of participants with presbyopia by using a battery of validated and investigator-developed instruments\n\n* Improvement in presbyopic symptoms as measured with the Near Activity Visual Questionnaire-Presbyopia (NAVQ-P) when using Qlosi™ at week 4 compared to baseline (continuous variable).\n* Improvement in presbyopic symptoms as measured with the Visual Quality of Life with Time Survey (VisQualT) questionnaire when using Qlosi™ at week 4 compared to baseline.",[69,28,70],"Presbyopia","Dry Eye","RECRUITING","2025-08-07",{"date":74,"type":45},"2025-08-12",{"date":76,"type":45},"2025-07-18",{"date":78,"type":20},"2025-11-15",{"name":80,"class":52},"Southern College of Optometry",2,{"id":83,"slug":84,"hasResults":11,"nctId":85,"briefTitle":86,"officialTitle":87,"acronym":88,"eligibilityCriteria":89,"healthyVolunteers":16,"sex":17,"minAge":90,"maxAge":4,"enrollmentInfo":91,"targetDuration":4,"studyType":21,"phases":93,"briefSummary":94,"conditions":95,"keywords":99,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":104,"lastUpdatePostDateStruct":105,"startDateStruct":107,"completionDateStruct":109,"leadSponsor":111,"locationsCount":53},"100528465","filter-lenses-for-the-prevention-of-migraine-attacks-100528465","NCT06161129","Filter Lenses for the Prevention of Migraine Attacks","Filter Lenses for the Prevention of Migraine Attacks - Effects of Blue Cut and FL-41 Filter Lenses","COMFORT","Inclusion criteria:\n\n* Adult individuals below the age of 66.\n* Diagnosed with migraine by a neurologist.\n* Able to communicate in Danish\n* Able to voluntarily come to the clinic during an untreated migraine attack.\n* Must have had migraine attacks for more than 1 year.\n\nExclusion criteria:\n\n* Fewer than four migraine attacks per month.\n* Chronic neck pain\n* Chronic headache\n* Chronic use of opioids\n* Presence of a pathological eye condition (in the study, an eye condition is defined as a permanent eye condition that affects the front and back of the eye, such as glaucoma, age-related macular degeneration)\n* Other acquired and congenital retinal diseases must not be present.\n* If there is more than 1 line of deviation on the Snellen chart from habitual correction to best correction, the participant must have a new pair of glasses made at their own expense.","18 Years",{"count":92,"type":20},200,[23],"The purpose is to investigate whether the Blue Cut for Night filter is better at reducing migraine compared to the FL-41 filter or a filter blocking light below 500 nm. A control group will use clear lenses without filter. This is a controlled, randomized and double-blind trial.",[96,28,97,98],"Migraine","Headache","Visual Impairment",[96,100,101,102,103],"filter glasses","pain","headache","treatment","2024-12-04",{"date":106,"type":45},"2024-12-09",{"date":108,"type":20},"2026-03-01",{"date":110,"type":20},"2029-02-01",{"name":112,"class":52},"Rune Skovgaard Rasmussen"]